-transparent.png){kind=logo}
Oral high-dose medroxyprogesterone acetate (MPA) treatment (600, 800, 1200 mg/day or changed dosage) was given to 49 patients with recurrent breast cancer from January 1979 to December 1992. The overall response rate to MPA was 38.8% (19/49). The response rate in the soft tissue was significantly higher compared with that in bone metastases or in visceral metastases. MPA was effective on patients both with or without previous treatment. Several side effects were recognized, but they were mild and tolerable. These results demonstrate that MPA is effective when used as first line or second line treatment.
Related Publications
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
June 1984,
Australian and New Zealand journal of medicine,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
November 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
November 1993,
Gan to kagaku ryoho. Cancer & chemotherapy,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
December 1985,
The Southeast Asian journal of tropical medicine and public health,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
January 1984,
Cancer chemotherapy and pharmacology,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
October 1982,
European journal of cancer & clinical oncology,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
June 1986,
Cancer treatment reports,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
September 1982,
Cancer treatment reports,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
October 1979,
Tumori,
Y Iino, and
T Takeo, and
N Sugamata, and
H Aoyagi, and
Y Takai, and
H Takei, and
T Ando, and
Y Koibuchi, and
T Yokoe, and
S Ohwada
April 1999,
Breast cancer (Tokyo, Japan),
